Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
about
Cap-Independent Translational Control of CarcinogenesisCould the eIF2α-Independent Translation Be the Achilles Heel of Cancer?Pituitary adenomas: historical perspective, surgical management and future directionsThe molecular pathogenesis of pituitary adenomas: an updateSmall RNAs with big implications: new insights into H/ACA snoRNA function and their role in human diseaseInhibition of human dyskerin as a new approach to target ribosome biogenesisRibosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterningLoss of Drosophila pseudouridine synthase triggers apoptosis-induced proliferation and promotes cell-nonautonomous EMT.Specialized ribosomes: a new frontier in gene regulation and organismal biology.New frontiers in translational control of the cancer genomeThe cancerous translation apparatusDyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosisRibosomopathies: mechanisms of disease.Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.RNA regulons in Hox 5' UTRs confer ribosome specificity to gene regulation.Inactivation of X-linked tumor suppressor genes in human cancer.Far upstream element binding protein 1 activates translation of p27Kip1 mRNA through its internal ribosomal entry siteCUG-binding protein represses translation of p27Kip1 mRNA through its internal ribosomal entry siterRNA pseudouridylation defects affect ribosomal ligand binding and translational fidelity from yeast to human cells.Reversible induction of translational isoforms of p53 in glucose deprivation.A mass spectrometry-based method for comprehensive quantitative determination of post-transcriptional RNA modifications: the complete chemical structure of Schizosaccharomyces pombe ribosomal RNAsTranslational control in cancer etiology.Small molecule inhibitors of IRES-mediated translation.H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment.The molecular pathogenesis of corticotroph tumours.Translational control in cellular and developmental processes.RNA binding protein/RNA element interactions and the control of translationRegulation of snoRNAs in cancer: close encounters with interferon.Translation factors and ribosomal proteins control tumor onset and progression: how?p27 and leukemia: cell cycle and beyond.H/ACA Box Small Nucleolar RNA 7A Promotes the Self-Renewal of Human Umbilical Cord Mesenchymal Stem Cells.Etiology and pathogenesis of the cohesinopathies.Transcriptome-wide dynamics of RNA pseudouridylation.Requirement of rRNA methylation for 80S ribosome assembly on a cohort of cellular internal ribosome entry sites.Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation.Investigating Myc-dependent translational regulation in normal and cancer cells.RNA Pseudouridylation in Physiology and Medicine: For Better and for Worse.Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function.
P2860
Q26744030-F6CE0BE2-BBA7-40A8-BE22-DD5FCDFA8447Q26774488-3C9E6FF1-033E-4184-AF07-FDEC368F7EDEQ26779749-0225A444-DF72-434E-935C-54C4B40831B7Q26830047-9AA715E7-1BAA-45C0-BA1B-E7A350814757Q27016076-2EB1F4CF-3FBD-416B-A8B6-B91E3E4AD55EQ28540640-DC65E5BC-16F6-4C23-BA2A-6046153584BCQ28591034-DEF45C67-2B56-47B2-A900-578308D9DEA7Q30635913-D8A4D216-F123-4D6C-9582-668195688F6CQ33689623-F96439A9-E754-4F9B-B61B-39EEBBD2C2EDQ33853235-A2BED592-8C0B-4CA1-A766-EC8E859C8FAFQ34182649-CC9DAF39-3CFB-4DC3-8CC7-6D72E1F1F970Q34389344-1C885A11-8059-40F8-AB8B-457390DDFA5BQ34454066-A9FC0414-1248-4917-A638-436EF3CCC761Q35053490-759D3C89-E80E-41EC-810D-C39BEE7BC362Q35159261-A9C6FEB5-3457-4BED-A118-4510BE7BC423Q35206452-4CC184AD-260D-462F-9263-4D0930C6F92CQ35508030-286DDF20-BAC1-4443-B7FF-77F60311A48DQ35556762-DE956D03-8306-4215-8732-64E4F7615B56Q35569577-4115C264-D808-445D-BAA6-2763446031A3Q36067769-78B85D4D-D1EA-42AD-AEB7-31EBF8E6D190Q36160571-1FE5DCAD-65EB-4948-A9B6-190B61B32CADQ36555212-ED575F77-7D17-48BD-9212-82AD42CF1F3CQ36838887-0542EEF8-FACA-4ECE-B8D4-A5FC80486FACQ37378023-8B9F550B-F551-4E8F-936B-EA16F0DA7463Q37482750-54E10539-B53E-4321-B6A6-9B4EB7DDEB3EQ37958029-AED48EE7-CD81-4DA3-8D84-17565CEE67EFQ38008495-C628EE51-07A2-47E5-9F3E-464E9F676C97Q38019544-AB7B243A-707A-40CA-83EA-681986DD565CQ38097516-8D9E63BC-D449-494F-A985-0221E64FFEDAQ38104237-50214F7E-1466-4A21-8087-B7122E1C63F5Q38247694-50A301B5-418F-4240-879C-55CDB31E5A29Q38291092-4314AE14-6FCF-4018-854E-BCF8C818C9FCQ38408256-50933857-7B5E-402D-BC90-DC8B55BCE598Q38569103-BD5C2851-E8E6-4546-A8EA-87FD094BE69DQ38959104-C1569435-1F3F-42BF-9113-6F847EBBF593Q39081916-04D2FF14-7998-4421-BD7F-BD6C4C2E2F43Q39131220-6FC43C35-AC09-4CBC-8169-32864F49F7E2Q39401386-5F32A112-A2D7-48F1-9242-5B0B5C5A9406Q46268612-11599B35-622F-4749-AB34-9ACAC7271A2FQ46904858-C5D6C071-752E-4296-A631-8DDE9A2142AB
P2860
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@ast
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@en
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@nl
type
label
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@ast
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@en
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@nl
prefLabel
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@ast
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@en
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@nl
P2093
P2860
P1433
P1476
Loss of function of the tumor ...... es to pituitary tumorigenesis.
@en
P2093
Cristian Bellodi
Davide Ruggero
Guang Peng
Lorenzo Montanaro
Marily Theodoropoulou
Nikesha Haynes
Olya Krasnykh
P2860
P304
P356
10.1158/0008-5472.CAN-09-4730
P407
P577
2010-06-29T00:00:00Z